Moneycontrol PRO
HomeNewsBusinessStocksBuy, Sell, Hold: Analysts are tracking these 4 stocks today

Buy, Sell, Hold: Analysts are tracking these 4 stocks today

Tata Steel and Welspun India, among others, are on the radar of investors on Tuesday.

August 08, 2017 / 08:34 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Tata Steel

    Brokerage: CLSA | Rating: Buy | Target: Raised to Rs 800

    The brokerage house observed that the company’s margin expectedly dipped quarter on quarter in both India and Europe, but still better than estimates. Further, it believes that the multiples can expand on high possibility of de-risking in Tata Steel Europe.

    Brokerage: Morgan Stanley | Rating: Overweight | Target: Rs 625

    The global brokerage firm said that the domestic operating profit was a miss, but Europe surprised positively. Further, it said that benefits of Kalinganagar ramp-up will be a key positive for better earnings momentum. It also believes that benign coking coal prices could be offset by high iron ore cost for European business.

    Brokerage: Credit Suisse | Rating: Outperform | Target: Raised to Rs 720

    Credit Suisse said that the operating profit for quarter under review beat its consensus estimates for India and Europe by 27 percent. Further, it added, the management continues to expect a final agreement on the UK Pension Resolution shortly. It also said that the current fiscal’s earnings per share (EPS) fell 30 percent on a different accounting treatment of Tata Motors stake sale under IndAS accounting system.

    Apollo Tyres

    Brokerage: Credit Suisse | Rating: Downgrade to Underperform | Target: Rs 240

    The brokerage observed that the headwinds for this fiscal include virtually no pricing action in India or Europe. While the anti-dumping duty will be positive, it reckons the stock price already reflects this. Further, a raw material inflation should abate as rubber prices have started to come off.

    Welspun India

    Brokerage: Credit Suisse | Rating: Outperform | Target: Rs 115

    Credit Suisse said that there were no surprises in Q1 results, while the management retained FY18 outlook in mid-single digit revenue growth.

    Dr Lal Pathlabs

    Brokerage: CLSA | Rating: Buy | Target: Rs 1,120

    CLSA said that the company saw encouraging volume growth and some recovery after two disappointing quarters. The volume growth of 9 percent due to high base of the first quarter of last year was a key positive, it added. The company also increased margin expectation to 25-27 percent against 25 percent earlier, it added. Going forward, the company’s Kolkata lab beginning operations in the third quarter could be the next growth driver, it added.

    first published: Aug 8, 2017 08:34 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347